Seven Eight Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Seven Eight Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,352	Closed	-$2.98M	–	968
2024 Q2	$2.98M	Buy	+6,352	New	+$2.98M	0.31%	70
2024 Q1	–	Sell	-1,376	Closed	-$560K	–	844
2023 Q4	$560K	Sell	1,376 -32,168	-96%	-$13.1M	0.06%	400
2023 Q3	$11.7M	Buy	33,544 +23,206	+224%	+$8.07M	1.36%	6
2023 Q2	$3.64M	Buy	10,338 +9,661	+1,427%	+$3.4M	0.6%	35
2023 Q1	$213K	Sell	677 -13,249	-95%	-$4.17M	0.04%	393
2022 Q4	$4.02M	Buy	13,926 +10,611	+320%	+$3.06M	1.05%	14
2022 Q3	$960K	Buy	+3,315	New	+$960K	0.19%	163
2021 Q4	–	Sell	-8,676	Closed	-$1.57M	–	692
2021 Q3	$1.57M	Buy	+8,676	New	+$1.57M	0.15%	225
2021 Q2	–	Sell	-3,209	Closed	-$758K	–	718
2021 Q1	$758K	Hold	3,209	–	–	0.17%	204
2020 Q4	$758K	Buy	+3,209	New	+$758K	0.17%	207
2020 Q1	–	Sell	-5,239	Closed	-$1.15M	–	730
2019 Q4	$1.15M	Sell	5,239 -60,200	-92%	-$13.2M	0.06%	434
2019 Q3	$11.1M	Buy	65,439 +8,167	+14%	+$1.38M	0.59%	35
2019 Q2	$10.5M	Buy	57,272 +10,500	+22%	+$1.93M	0.55%	43
2019 Q1	$8.6M	Buy	46,772 +8,572	+22%	+$1.58M	0.45%	58
2018 Q4	$6.33M	Buy	38,200 +13,500	+55%	+$2.24M	0.35%	91
2018 Q3	$4.76M	Sell	24,700 -18,200	-42%	-$3.51M	0.29%	101
2018 Q2	$7.29M	Sell	42,900 -9,400	-18%	-$1.6M	0.51%	61
2018 Q1	$8.52M	Buy	52,300 +25,800	+97%	+$4.2M	0.7%	46
2017 Q4	$3.97M	Sell	26,500 -21,100	-44%	-$3.16M	0.41%	73
2017 Q3	$7.24M	Buy	47,600 +37,600	+376%	+$5.72M	0.88%	10
2017 Q2	$1.29M	Sell	10,000 -30,900	-76%	-$3.98M	0.19%	173
2017 Q1	$4.47M	Buy	40,900 +2,700	+7%	+$295K	0.87%	21
2016 Q4	$2.81M	Buy	38,200 +30,500	+396%	+$2.25M	0.57%	32
2016 Q3	$672K	Buy	7,700 +4,200	+120%	+$367K	0.2%	177
2016 Q2	$301K	Buy	+3,500	New	+$301K	0.1%	268
2015 Q4	–	Sell	-6,800	Closed	-$708K	–	699
2015 Q3	$708K	Buy	6,800 +6,100	+871%	+$635K	0.62%	41
2015 Q2	$86K	Buy	+700	New	+$86K	0.1%	280
2014 Q4	–	Sell	-1,600	Closed	-$180K	–	669
2014 Q3	$180K	Buy	+1,600	New	+$180K	0.14%	241